Thus, combination treatment of doxorubicin and TβRI-KI effectively enhanced the inhibition of both tumor growth and spontaneous lung metastasis of murine 4T1 cells in comparison to the single treatments. This evidence concerns the gene TGFBR1 and neoplasm.